Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.94 USD
Change Today +0.01 / 1.08%
Volume 343.7K
IBIO On Other Exchanges
As of 8:04 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Douglas J. Beck CPA

Former Senior Adviser, iBio, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2013


Mr. Douglas J. Beck, CPA, also known as Doug has been the Chief Financial Officer of Relmada Therapeutics, Inc. (formerly, TheraQuest Biosciences, Inc) since December 2, 2013. Mr. Beck served as the Chief Financial Officer of iBio, Inc. from May 3, 2011 to February 21, 2013 and as its Principal Accounting Officer until February 21, 2013. He served as Senior Adviser of iBio, Inc. from February 21, 2013 to March 2013. He served as the Chief Financial Officer of Lev Pharmaceuticals, ...

Read Full Background

Corporate Headquarters*

9 Innovation Way
Newark, Delaware 19711

United States

Phone: 302-355-0650
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


BS 1983
Fairleigh Dickinson University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$140,000

Stock Options*

Unexercisable Options334,199
Total Number of Options334,199

Total Compensation*

Total Annual Cash Compensation$140,000
Total Short Term Compensation$140,000
Total Calculated Compensation$140,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IBIO:US $0.94 USD +0.01


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IBIO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at